AR123279A1 - ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF - Google Patents
ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOFInfo
- Publication number
- AR123279A1 AR123279A1 ARP210102323A ARP210102323A AR123279A1 AR 123279 A1 AR123279 A1 AR 123279A1 AR P210102323 A ARP210102323 A AR P210102323A AR P210102323 A ARP210102323 A AR P210102323A AR 123279 A1 AR123279 A1 AR 123279A1
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- immunoconjugates
- provides
- conjugates
- pharmaceutical compositions
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La invención proporciona anticuerpos que se unen a la proteína CEACAM5 humana, así como ácidos nucleicos aislados y células huésped que comprenden una secuencia que codifica dichos anticuerpos. La invención también proporciona inmunoconjugados que comprenden dichos anticuerpos unidos a un agente inhibidor del crecimiento y composiciones farmacéuticas que comprenden anticuerpos o inmunoconjugados de la invención. La invención también proporciona el uso de los anticuerpos, inmunoconjugados y composiciones farmacéuticas de la invención para el tratamiento del cáncer o con fines de diagnóstico.The invention provides antibodies that bind to the human CEACAM5 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding such antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth inhibitory agent and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides the use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP20194711 | 2020-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR123279A1 true AR123279A1 (en) | 2022-11-16 |
Family
ID=72422079
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP210102323A AR123279A1 (en) | 2020-09-04 | 2021-08-18 | ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF |
Country Status (1)
Country | Link |
---|---|
AR (1) | AR123279A1 (en) |
-
2021
- 2021-08-18 AR ARP210102323A patent/AR123279A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2023004252A2 (en) | Anti-ceacam5 antibodies and conjugates and uses thereof | |
DOP2015000110A (en) | ANTI-CEACAM5 ANTIBODIES AND USES OF THESE | |
PE20211284A1 (en) | ANTI-NKG2A ANTIBODIES AND USES OF THEM | |
CO2018014010A2 (en) | Alpha-synuclein antibodies and uses thereof | |
EA201700181A1 (en) | COMPOSITIONS OF ADENOSINDEMINASE-2 (ADA-2), THEIR OPTIONS AND METHODS OF USE | |
CL2020002144A1 (en) | Multispecific binding proteins that bind to cd33, nkg2d and cd16 and methods of use, (request hna 2143) | |
UY35250A (en) | ANTI-LAMP1 ANTIBODIES AND CONJUGATES ANTIBODY DRUG, AND USES OF THESE. | |
CO2022002573A2 (en) | Antibodies against ilt2 and their use | |
BR112022008756A2 (en) | ANTI-MESOTHELIN ERIBULIN ANTIBODY-DRUG CONJUGATES AND METHODS OF USE | |
CO2023017609A2 (en) | Multispecific anti-cea and anti-cd137 antibodies and methods of use | |
CY1126032T1 (en) | ANTIBODY-DRUG CONJUGATIONS TARGETING UPARAP | |
CO2024003578A2 (en) | Antibodies capable of binding to CD27, variants and their uses | |
EA202192488A1 (en) | ANTIBODIES AGAINST TSG-6 AND THEIR APPLICATIONS | |
ECSP20020949A (en) | ANTI-EGFR DRUG-ANTIBODY CONJUGATES (ADC) AND THEIR USES | |
BR112022009482A2 (en) | MONOCLONAL ANTI-B7-H3 ANTIBODY AND METHODS OF USE THEREOF | |
AR123279A1 (en) | ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF | |
CO2023002375A2 (en) | Antibodies against ilt2 and use thereof | |
BR112021010634A2 (en) | Antiperiostin antibodies and their uses | |
CL2022000107A1 (en) | Anti-grp78 antibodies and method of use thereof | |
AR128745A1 (en) | ANTI-CEACAM5 ANTIBODIES AND CONJUGATES AND USES THEREOF | |
AR128735A1 (en) | ANTI-GD2 ANTIBODIES, IMMUNOCONJUGATES AND THERAPEUTIC USES THEREOF | |
BR112021016102A2 (en) | fcmr binding molecules and uses thereof | |
AR125753A1 (en) | ANTI-TIGIT ANTIBODIES, ANTI-CD96 ANTIBODIES AND METHODS OF USE OF THESE | |
EA202191761A1 (en) | NEW CONJUGATED NUCLEIC ACID MOLECULES AND THEIR APPLICATION | |
CO2024007220A2 (en) | Compounds containing heteroatoms and uses of these |